BioTime announces issuance of 14 new patents
BioTime announced the issuance of 14 new patents covering a wide range of the core technologies of BioTime and its subsidiaries Asterias Biotherapeutics, OrthoCyte, ES Cell International, OncoCyte, and ReCyte Therapeutics. January 26, 2015